CLOV

3.59

2.97% -0.11

Handel nachbörslich: 3.59

Clover Health Investments Corp (CLOV)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CLOV? Forum Prognose

Schlusskurs vom Vortag:

$3.70

Offen:

$3.67

24-Stunden-Volumen:

5.05M

Relative Volume:

0.88

Marktkapitalisierung:

$1.89B

Einnahmen:

$1.70B

Nettoeinkommen (Verlust:

$-123.70M

KGV:

-13.48

EPS:

-0.2663

Netto-Cashflow:

$-178.21M

1W Leistung:

-3.49%

1M Leistung:

-9.57%

6M Leistung:

+27.30%

1J Leistung:

+352.14%

1-Tages-Spanne:

$3.495

$3.70

1-Wochen-Bereich:

$3.495

$3.91

52-Wochen-Spanne:

$0.606

$4.87

Clover Health Investments Corp Stock (CLOV) Company Profile

Firmenname

Clover Health Investments Corp

Sektor

Healthcare (1173)

Branche

Healthcare Plans (13)

Telefon

(201) 432-2133

Adresse

3401 MALLORY LANE, SUITE 210, FRANKLIN

Mitarbeiter

570

Twitter

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

CLOV's Discussions on Twitter

Vergleichen Sie CLOV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CLOV Clover Health Investments Corp	3.59	1.89B	1.70B	-123.70M	-178.21M	-0.2663
UNH Unitedhealth Group Inc	516.04	476.52B	400.28B	14.41B	20.71B	15.50
ELV Elevance Health Inc	432.00	98.20B	176.81B	5.98B	4.55B	25.61
CI Cigna Group	325.04	88.04B	244.38B	3.43B	8.96B	12.24
CVS Cvs Health Corp	67.14	85.19B	372.81B	4.61B	6.33B	3.66
HUM Humana Inc	264.58	32.63B	117.76B	1.21B	2.39B	9.95

Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-17	Eingeleitet	Craig Hallum	Buy
2024-10-07	Eingeleitet	UBS	Neutral
2022-02-02	Eingeleitet	Canaccord Genuity	Buy
2022-02-02	Hochstufung	Cowen	Underperform → Market Perform
2022-01-19	Eingeleitet	SVB Leerink	Mkt Perform
2022-01-10	Fortgesetzt	Citigroup	Neutral
2022-01-07	Herabstufung	Credit Suisse	Neutral → Underperform
2021-09-10	Eingeleitet	Cowen	Underperform
2021-09-02	Fortgesetzt	Citigroup	Neutral
2021-07-12	Herabstufung	JP Morgan	Neutral → Underweight
2021-06-10	Herabstufung	BofA Securities	Neutral → Underperform
2021-05-17	Herabstufung	BofA Securities	Buy → Neutral
2021-03-09	Eingeleitet	Credit Suisse	Neutral
2021-02-02	Eingeleitet	Citigroup	Buy
2021-02-01	Eingeleitet	JP Morgan	Neutral

Alle ansehen

Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten

Mar 25, 2025

Why Kindly MD (KDLY) Skyrocketed on Monday? - Yahoo Finance

Mar 25, 2025

Mar 22, 2025

Is Clover Health Investments (CLOV) the Best Stock to Invest in for a Stock Market Game? - MSN

Mar 22, 2025

Mar 19, 2025

3 Reasons CLOV Is Risky And 1 Stock To Buy Instead - Barchart

Mar 19, 2025

Mar 18, 2025

12 Best Stocks to Invest in for a Stock Market Game - Insider Monkey

Mar 18, 2025

Q4 Earnings Outperformers: Clover Health (NASDAQ:CLOV) And The Rest Of The Health Insurance Providers Stocks - Barchart

Mar 18, 2025

Mar 17, 2025

3 Promising Penny Stocks With Market Caps Over $1B - Simply Wall St

Mar 17, 2025

Mar 13, 2025

Is Clover Health Investments, Corp. (CLOV) the Best Multibagger Stock to Buy in 2025? - Insider Monkey

Mar 13, 2025

Mar 12, 2025

Clover Health director sells $722,000 in stock - Investing.com India

Mar 12, 2025

Clover Health director sells $722,000 in stock By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 11, 2025

12 Best Multibagger Stocks to Buy in 2025 - Insider Monkey

Mar 11, 2025

Clover Health at Leerink Global Healthcare: Tech-Driven Medicare Growth - Investing.com

Mar 11, 2025

Mar 08, 2025

Clover Health general counsel sells $199,500 in stock By Investing.com - Investing.com Australia

Mar 08, 2025

Clover Health’s CEO of home care sells $276,000 in stock By Investing.com - Investing.com Australia

Mar 08, 2025

Missed the Hims & Hers Rally? Clover Health Could Be Next - MSN

Mar 08, 2025

Insider Moves: Clean Energy, Warner Bros, Clover Health, Corning, TJX - TipRanks

Mar 08, 2025

Mar 07, 2025

Clover Health’s CEO of home care sells $276,000 in stock - Investing.com

Mar 07, 2025

Clover Health general counsel sells $199,500 in stock - Investing.com

Mar 07, 2025

After ‘Really Good’ Year, Insurtechs Look to Continue Growth in 2025 - MMITNetwork

Mar 07, 2025

Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth - Seeking Alpha

Mar 07, 2025

Mar 04, 2025

Decoding Clover Health Investments Corp (CLOV): A Strategic SWOT Insight - GuruFocus.com

Mar 04, 2025

Canaccord lifts Clover Health stock target to $4.50, maintains buy By Investing.com - Investing.com Australia

Mar 04, 2025

Clover Health’s Earnings Call Highlights Profitability and Growth - TipRanks

Mar 04, 2025

Clover Health Investments (NASDAQ:CLOV) Given New $4.50 Price Target at Canaccord Genuity Group - Defense World

Mar 04, 2025

Mar 03, 2025

Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians - The Manila Times

Mar 03, 2025

Can This Google Cloud Partnership Help Clover Health Solve the 28-Hour Administrative Burden Crushing Doctors? - StockTitan

Mar 03, 2025

Canaccord lifts Clover Health stock target to $4.50, maintains buy - Investing.com

Mar 03, 2025

CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-K Report - TradingView

Mar 03, 2025

Feb 28, 2025

Clover Health Investments (NASDAQ:CLOV) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Feb 28, 2025

Clover Health Investments (NASDAQ:CLOV) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Feb 28, 2025

Clover Health Investments (CLOV) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025

Clover Health Reports Q4 2024 Revenue of $337 Million, Missing E - GuruFocus.com

Feb 28, 2025

Clover Health Investments CorpOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire

Feb 28, 2025

CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises - Nasdaq

Feb 28, 2025

Clover Health Investments Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 28, 2025